Middle East and Africa Portable and Wearable Dialysis Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product Type ; End users, and Country
Market Introduction Portable dialysis device is used to reduce the disease burden by reducing or complete removal of dietary restrictions.Although dialysis machines are lifesavers, much attention is not paid to them by the medical device industry.
Portable dialysis machines are specifically designed for home use or during travelling.Portable dialysis machines can considerably improve the quality of life by allowing patients to have dialysis while going around their daily activities.
Wearable dialysis machines, also called a wearable artificial kidney, are disassembled dialysis equipment, separate parts of which are fixed on to a belt which can be worn around the torso.
Market Overview and Dynamics The Middle East and Africa portable and wearable dialysis devices market is projected to reach US$ 202.12 million by 2027 from US$ 152.54 million in 2019. The market is anticipated to grow with a CAGR of 3.8% from 2020 to 2027. The growth of the Middle East and portable and wearable dialysis devices market is attributed to increasing prevalence of chronic kidney conditions and end stage renal diseases. Further, increasing adoption of wearable dialysis devices and government policies to spread awareness regarding dialysis are also projected to drive the market growth during the forecast period. In addition, growing number of technological advancements in dialysis devices to deal with chronic kidney conditions are also anticipated to accelerate the market growth. The outbreak of the COVID-19 pandemic is estimated to less impact on the portable and wearable dialysis device market during the forecast period. It is likely to owe several growth opportunities for the market in the coming years. However, at present and in the following few years is expected to show a negative impact on market growth.
Key Market Segments Based on product type, the Middle East and Africa portable and wearable dialysis devices market is segmented into hemodialysis and peritoneal dialysis.In 2019, the hemodialysis product type segment held a larger share of the market.
Also, the segment is expected to grow at a faster rate during the forecast period.
Major Sources and Companies Listed A few major primary and secondary sources referred to while preparing the Middle East and Africa portable and wearable dialysis devices market report are World Health Organization, Ministry of Health and Prevention, and Ministry of Health and Family Welfare.
MIDDLE EAST AND AFRICA PORTABLE AND WEARABLE DIALYSIS DEVICES MARKET SEGMENTATION By Product Type • Hemodialysis • Peritoneal Dialysis By End User • Hospital • Clinic • Home By Country • Saudi Arabia • UAE • South Africa • Rest of Middle East and Africa Company Profiles • B. Braun Melsungen AG • Baxter International Inc. • Asahi Kasei Corporation • Fresenius Kabi AG • Medtronic
Our reports have been used by over 10K customers, including:
Market Introduction The Liposome are novel drug delivery system (NDDS), they are vesicular structures consisting of bilayers which form spontaneously when phospholipids are disappeared in water. They are microscopic vesicles in which an aqueous volume is entirely enclosed by a membrane composed of lipid bilayers. Market Overview...
Rising prevalence for chronic diseases and growth in the biologics market are expected to drive the overall growth of the pharmaceutical drug delivery market. The global pharmaceutical drug delivery market is projected to reach USD 2,015.3 billion by 2025 from USD 1,430.5 billion in 2020, at a CAGR of 7.1% during the forecast period 2020-2025....
The Asia Pacific Wearable Injectors market is expected to reach US$ 2939.97 million by 2027 from US$ 1160.40 million in 2019. The market is estimated to grow at CAGR of 12.4% from 2020 to 2027. The growth of the market is driven by the factors such as, increasing chronic diseases prevalence, technological advancements and design development,...
The Europe wearable injectors market is expected to reach US$ 3586.82 million in 2027 from US$ 1539.88 million in 2019. The market is estimated to grow with a CAGR of 11.3 % from 2020 to 2027. The growth of the market is driven by the factors such as, increasing chronic diseases prevalence, technological advancements and design development,...
The North America wearable injectors Market is projected to reach US$ 5767.51 million by 2027 from US$ 2370.52 million in 2019. The market is estimated to grow at CAGR of 11.9% from 2020 to 2027. The growth of the market is driven by the factors such as, increasing chronic diseases prevalence, technological advancements and design development,...
The liposome drug delivery market is expected to reach US$ 6,992.95 million by 2027 from US$ 3,594.41 million in 2019. The market is estimated to grow at a CAGR of 8.8% from 2020 to 2027.
The growth of the market is attributed to a few key driving factors such as increasing prevalence of chronic diseases, growing demand for noninvasive...
The bioresorbable medical material was valued at US$ 935.99 million in 2019 and is expected to grow at a CAGR of 9.7% from 2020 to 2027 to reach US$ 1,942.13 million by 2027. Driving factors of the bioresorbable medical material market are rising adoption of bioresorbable polymers for medical use and increasing number of orthopedic...
The electronic drug delivery systems market is projected to grow at a CAGR of 8.7% during the forecast period (2019–2024). The electronic drug delivery systems market is projected to reach USD 11.9 billion by 2024 from USD 7.8 billion in 2019, at a CAGR of 8.7%. The growth of the electronic drug delivery systems market...
The global transradial access market is expected to reach US$ 2,961.79 Mn in 2027 from US$ 1,574.97 Mn in 2018. The market is estimated to grow with a CAGR of 7.7% from 2019-2027. The market for transradial access is expected to grow, owing to factors such as rising inclination for interventional procedures using radial artery access, increasing...
The Europe drug delivery systems market is expected to reach US$ 610,320.4 Mn in 2027 from US$ 343,533.9 in 2018. The market is estimated to grow with a CAGR of 6.7% from 2019-2027. Factors such as rising investments by pharmaceutical companies and medical device companies in research and development and rise of chronic disease conditions...
Drug Delivery
Europe
Diabetes Prevalence
Chronic Disease Prevalence
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.